Jbm (Healthcare) Ltd
HKEX:2161
Jbm (Healthcare) Ltd
Cash from Financing Activities
Jbm (Healthcare) Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Jbm (Healthcare) Ltd
HKEX:2161
|
Cash from Financing Activities
-HK$56m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
Cash from Financing Activities
-¥1B
|
CAGR 3-Years
19%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
S
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Cash from Financing Activities
-¥5.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-30%
|
C
|
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
|
Cash from Financing Activities
-¥882.4m
|
CAGR 3-Years
5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Cash from Financing Activities
-HK$6.2B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
HUTCHMED (China) Ltd
LSE:HCM
|
Cash from Financing Activities
$48.7m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
14%
|
See Also
What is Jbm (Healthcare) Ltd's Cash from Financing Activities?
Cash from Financing Activities
-56m
HKD
Based on the financial report for Mar 31, 2023, Jbm (Healthcare) Ltd's Cash from Financing Activities amounts to -56m HKD.
What is Jbm (Healthcare) Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-30%
Over the last year, the Cash from Financing Activities growth was 27%. The average annual Cash from Financing Activities growth rates for Jbm (Healthcare) Ltd have been 2% over the past three years , -30% over the past five years .